ArticleCancers2023

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated.

Alexandra McLean Stevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.